Hester Biosciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2018. For the quarter, the company reported total revenue of INR 421.13 million compared to INR 322.96 million a year ago. Profit for period was INR 118.59 million compared to INR 65.01 million a year ago. Income from operations was INR 415.56 million compared to INR 319.25 million a year ago. Basic and diluted earnings per share was INR 13.94 compared to INR 7.64 a year ago. For the nine months, the company reported total revenue of INR 1,239.74 million compared to INR 993.23 million a year ago. Profit for period was INR 314.75 million compared to INR 215.44 million a year ago. Income from operations was INR 1,223.58 million compared to INR 977.69 million a year ago. Basic and diluted earnings per share was INR 37.00 compared to INR 25.33 a year ago.